Extracorporeal circulation impairs microcirculation perfusion and organ function.


Journal

Journal of applied physiology (Bethesda, Md. : 1985)
ISSN: 1522-1601
Titre abrégé: J Appl Physiol (1985)
Pays: United States
ID NLM: 8502536

Informations de publication

Date de publication:
01 03 2022
Historique:
pubmed: 28 1 2022
medline: 4 5 2022
entrez: 27 1 2022
Statut: ppublish

Résumé

Extracorporeal membrane oxygenation (ECMO) is a procedure used to aid respiratory function in critical patients, involving extracorporeal circulation (ECC) of blood. There is a limited number of studies quantifying the hemodynamic effects of ECC procedures on the microcirculation. We sought to mimic veno-arterial-ECMO flow conditions by use of a scaled-down circuit primed with either lactate Ringer (LR) or 5% human serum albumin (HSA). The circuit was first tested using benchtop runs with blood, and subsequently used for in vivo experiments in Golden Syrian hamsters instrumented with a dorsal window chamber to allow for quantification of microvascular hemodynamics and functional capillary density (FCD). Results showed significant impairment in FCD, and a reduction of arteriolar and venular blood flow, with HSA providing significant higher blood flows and FCD compared with LR. Changes in hematocrit and RBC labeling after ECC reflected a shift in plasma volume, which may stem from a loss in intravascular oncotic pressure due to priming fluids. The distribution of hemoglobin oxygen saturation in the microvasculature showed a significant decrease in venules after ECC. In addition, major organs such as the kidney and heart showed increases in both inflammatory and damage markers. These results suggest that ECC impairs microvasculature function and promotes ischemia and hypoxia in the tissues, which can be vital to understanding comorbid clinical outcomes from ECC procedures such as acute kidney injury and multiorgan dysfunction.

Identifiants

pubmed: 35085033
doi: 10.1152/japplphysiol.00726.2021
pmc: PMC8917920
doi:

Substances chimiques

Oxygen S88TT14065

Banques de données

figshare
['10.6084/m9.figshare.c.5672074']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

794-810

Subventions

Organisme : NIH HHS
ID : R01HL162120
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL159862
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL138116
Pays : United States
Organisme : NIH HHS
ID : R01HL159862
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL162120
Pays : United States

Références

J Thorac Dis. 2019 Sep;11(Suppl 14):S1688-S1697
pubmed: 31632746
PLoS One. 2018 Oct 11;13(10):e0205437
pubmed: 30308065
Liver Int. 2008 May;28(5):592-605
pubmed: 18433389
Biochim Biophys Acta. 2010 Aug;1800(8):760-9
pubmed: 20304033
Microvasc Res. 1973 May;5(3):309-12
pubmed: 4709728
J Thorac Cardiovasc Surg. 1990 Oct;100(4):538-45
pubmed: 2145479
Mediators Inflamm. 2015;2015:412319
pubmed: 25705092
Front Med (Lausanne). 2018 Aug 17;5:228
pubmed: 30175099
Ann Am Thorac Soc. 2016 Dec;13(12):2242-2250
pubmed: 27690525
Circ Heart Fail. 2018 Sep;11(9):e004905
pubmed: 30354364
Physiol Rev. 2003 Jul;83(3):933-63
pubmed: 12843412
Blood. 1980 Jan;55(1):156-9
pubmed: 7350935
Lab Invest. 2014 Feb;94(2):150-60
pubmed: 24365747
CMAJ. 2005 Nov 8;173(10):1191-202
pubmed: 16275971
Microvasc Res. 2003 Sep;66(2):77-82
pubmed: 12935765
Scand J Clin Lab Invest. 1960;12:177-86
pubmed: 13848805
Eur J Cardiothorac Surg. 2004 Sep;26(3):564-70
pubmed: 15302052
Eur J Cardiothorac Surg. 2005 Aug;28(2):259-65
pubmed: 15951194
Ann Intensive Care. 2018 Dec 20;8(1):129
pubmed: 30570687
J Cardiothorac Vasc Anesth. 2004 Aug;18(4):429-37
pubmed: 15365922
Ann Thorac Surg. 2014 Feb;97(2):610-6
pubmed: 24210621
Ann Thorac Surg. 1993 Feb;55(2):552-9
pubmed: 8431082
Crit Care. 2016 Nov 28;20(1):387
pubmed: 27890016
Front Physiol. 2019 Oct 30;10:1350
pubmed: 31736778
Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H330-5
pubmed: 15961377
ASAIO J. 2015 Sep-Oct;61(5):589-95
pubmed: 26102178
J Physiol. 1896 May 5;19(4):312-26
pubmed: 16992325
Clin Hemorheol Microcirc. 2004;31(2):139-48
pubmed: 15310949
Thorac Cardiovasc Surg. 2001 Jun;49(3):157-61
pubmed: 11432474
J Intensive Care Med. 2011 Jan-Feb;26(1):13-26
pubmed: 21262750
Cardiovasc Res. 2006 Feb 1;69(2):318-28
pubmed: 16289003
Sci Rep. 2016 Sep 14;6:33123
pubmed: 27625115
ASAIO J. 2019 Nov/Dec;65(8):812-818
pubmed: 30312207
J Appl Physiol. 1967 Feb;22(2):333-7
pubmed: 6017904
Intensive Care Med. 2018 Mar;44(3):281-299
pubmed: 29411044
Nat Rev Rheumatol. 2010 Apr;6(4):232-41
pubmed: 20177398
Adv Drug Deliv Rev. 2017 Mar;112:12-23
pubmed: 28042080
Res Exp Med (Berl). 1980;177(2):125-34
pubmed: 7003665
Lab Invest. 2010 Jan;90(1):128-39
pubmed: 19901912
Circulation. 1999 Jan 19;99(2):237-42
pubmed: 9892589
Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):46
pubmed: 31346840
Int Anesthesiol Clin. 2007 Spring;45(2):27-37
pubmed: 17426506
Pediatr Res. 2010 Aug;68(2):128-33
pubmed: 20442689
J Mater Chem B. 2018 Oct 21;6(39):6225-6233
pubmed: 32254613
Biomaterials. 2004 Nov;25(26):5681-703
pubmed: 15147815
Eur J Cardiothorac Surg. 1997 May;11(5):973-80
pubmed: 9196317

Auteurs

Krianthan Govender (K)

Functional Cardiovascular Engineering Laboratory, Bioengineering Department, University of California San Diego, La Jolla, California.

Pedro Cabrales (P)

Functional Cardiovascular Engineering Laboratory, Bioengineering Department, University of California San Diego, La Jolla, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH